Cover Image
市場調查報告書

髖關節重組:開發平台分析

Hip Reconstruction - Medical Devices Pipeline Assessment, 2016

出版商 GlobalData 商品編碼 341587
出版日期 內容資訊 英文 169 Pages
訂單完成後即時交付
價格
Back to Top
髖關節重組:開發平台分析 Hip Reconstruction - Medical Devices Pipeline Assessment, 2016
出版日期: 2016年12月01日 內容資訊: 英文 169 Pages
簡介

本報告提供全球各國的企業·醫療機關等正在開發的髖關節重組之開發中產品資訊分析,提供您臨床實驗與產品開發的進展,各階段·各市場區隔·國家 (地區) 別趨勢,企業與產品詳細資訊,最近的產品開發及產業趨勢等資訊。

第1章 目錄

第2章 簡介

  • 髖關節重組概要

第3章 開發中的產品

  • 髖關節重組 - 各開發階段的開發中產品
  • 髖關節重組 - 各市場區隔的開發中產品
  • 髖關節重組 -國家 (地區) 別的開發中產品
  • 髖關節重組 - 法規別的開發中產品
  • 髖關節重組 - 核准時期 (估計) 別的開發中產品
  • 髖關節重組 - 現在進行中的臨床實驗

第4章 髖關節重組 - 正在開發的開發中產品:各企業

  • 髖關節重組企業 - 各開發階段的開發中產品
  • 髖關節重組 - 各開發階段的開發中產品

第5章 髖關節重組企業與產品概要

  • Amedica Corporation
  • Bonovo Orthopedics, Inc.
  • Corentec Co., Ltd.
  • Corin Group Plc
  • DePuy Companies
  • Dimicron Inc.
  • Exactech, Inc.
  • Fortis Orthopedics
  • Fraunhofer Institute for Applied Polymer Research
  • Implants International Limited
  • INOR Orthopaedics
  • JRI Orthopaedics Ltd
  • 京瓷醫學
  • Limacorporate S.p.a.
  • MX Orthopedics, Corp.
  • Nano Interface Technology, Inc.
  • Naviswiss AG
  • OrthoGrid Systems
  • OrthoPediatrics Corp.
  • PLD Corporation Limited (Inactive)
  • PreSRV Ltd.
  • Renova Orthopedics, LLC
  • SAS HyPrevention
  • SINTEF
  • Stryker Corporation
  • Tech Manage Corp.
  • University of Alberta
  • University of South Florida
  • University of Warwick
  • Zimmer Biomet Holdings, Inc.

第6章 髖關節重組 - 最近的趨勢

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0266EPD

GlobalData's Medical Devices sector report, "Hip Reconstruction - Medical Devices Pipeline Assessment, 2016" provides an overview of Hip Reconstruction currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hip Reconstruction pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Hip Reconstruction under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hip Reconstruction and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hip Reconstruction under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 7
  • 1.2 List of Figures 10

2 Introduction 11

  • 2.1 Hip Reconstruction Overview 11

3 Products under Development 13

  • 3.1 Hip Reconstruction - Pipeline Products by Stage of Development 13
  • 3.2 Hip Reconstruction - Pipeline Products by Segment 14
  • 3.3 Hip Reconstruction - Pipeline Products by Territory 15
  • 3.4 Hip Reconstruction - Pipeline Products by Regulatory Path 16
  • 3.5 Hip Reconstruction - Pipeline Products by Estimated Approval Date 17
  • 3.6 Hip Reconstruction - Ongoing Clinical Trials 18

4 Hip Reconstruction - Pipeline Products under Development by Companies 19

  • 4.1 Hip Reconstruction Companies - Pipeline Products by Stage of Development 19
  • 4.2 Hip Reconstruction - Pipeline Products by Stage of Development 21

5 Hip Reconstruction Companies and Product Overview 23

  • 5.1 4-Web Spine, LLC Company Overview 23
    • 5.1.1 4-Web Spine, LLC Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.2 Amedica Corporation Company Overview 24
    • 5.2.1 Amedica Corporation Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.3 Bonovo Orthopedics Inc Company Overview 26
    • 5.3.1 Bonovo Orthopedics Inc Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.4 Corentec Co., Ltd. Company Overview 28
    • 5.4.1 Corentec Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.5 DePuy Synthes Inc Company Overview 30
    • 5.5.1 DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.6 Exactech Inc Company Overview 36
    • 5.6.1 Exactech Inc Pipeline Products & Ongoing Clinical Trials Overview 36
  • 5.7 Fortis Orthopedics Company Overview 41
    • 5.7.1 Fortis Orthopedics Pipeline Products & Ongoing Clinical Trials Overview 41
  • 5.8 Fraunhofer Institute for Applied Polymer Research Company Overview 42
    • 5.8.1 Fraunhofer Institute for Applied Polymer Research Pipeline Products & Ongoing Clinical Trials Overview 42
  • 5.9 Implants International Limited Company Overview 44
    • 5.9.1 Implants International Limited Pipeline Products & Ongoing Clinical Trials Overview 44
  • 5.10 INOR Orthopaedics Company Overview 45
    • 5.10.1 INOR Orthopaedics Pipeline Products & Ongoing Clinical Trials Overview 45
  • 5.11 JRI Orthopaedics Ltd Company Overview 47
    • 5.11.1 JRI Orthopaedics Ltd Pipeline Products & Ongoing Clinical Trials Overview 47
  • 5.12 KYOCERA Medical Corp Company Overview 48
    • 5.12.1 KYOCERA Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 48
  • 5.13 Limacorporate S.p.a. Company Overview 49
    • 5.13.1 Limacorporate S.p.a. Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.14 MicroPort Scientific Corporation Company Overview 52
    • 5.14.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 52
  • 5.15 MX Orthopedics, Corp. Company Overview 56
    • 5.15.1 MX Orthopedics, Corp. Pipeline Products & Ongoing Clinical Trials Overview 56
  • 5.16 Nano Interface Technology LLC (Inactive) Company Overview 57
    • 5.16.1 Nano Interface Technology LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 57
  • 5.17 OrthoGrid Systems Company Overview 58
    • 5.17.1 OrthoGrid Systems Pipeline Products & Ongoing Clinical Trials Overview 58
  • 5.18 PLD Corporation Limited (Inactive) Company Overview 59
    • 5.18.1 PLD Corporation Limited (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 59
  • 5.19 PreSRV Ltd. Company Overview 60
    • 5.19.1 PreSRV Ltd. Pipeline Products & Ongoing Clinical Trials Overview 60
  • 5.20 Renova Orthopedics, LLC Company Overview 61
    • 5.20.1 Renova Orthopedics, LLC Pipeline Products & Ongoing Clinical Trials Overview 61
  • 5.21 Rochester Institute of Technology Company Overview 62
    • 5.21.1 Rochester Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 62
  • 5.22 SINTEF Company Overview 63
    • 5.22.1 SINTEF Pipeline Products & Ongoing Clinical Trials Overview 63
  • 5.23 Smith & Nephew Plc Company Overview 64
    • 5.23.1 Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview 64
  • 5.24 Stryker Corporation Company Overview 66
    • 5.24.1 Stryker Corporation Pipeline Products & Ongoing Clinical Trials Overview 66
  • 5.25 University of Alberta Company Overview 68
    • 5.25.1 University of Alberta Pipeline Products & Ongoing Clinical Trials Overview 68
  • 5.26 University of Auckland Company Overview 69
    • 5.26.1 University of Auckland Pipeline Products & Ongoing Clinical Trials Overview 69
  • 5.27 University of South Florida Company Overview 70
    • 5.27.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 70
  • 5.28 University of Warwick Company Overview 72
    • 5.28.1 University of Warwick Pipeline Products & Ongoing Clinical Trials Overview 72
  • 5.29 Zimmer Biomet Holdings Inc Company Overview 74
    • 5.29.1 Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 74

6 Hip Reconstruction- Recent Developments 79

  • 6.1 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 79
  • 6.2 Nov 15, 2016: Henry Ford Radiation Oncology Receives 3-Year ACR Accreditation 79
  • 6.3 Nov 14, 2016: First-ever functional, patient-specific hip replacement procedures performed in the USA 79
  • 6.4 Nov 10, 2016: Amedica Reports Third Quarter 2016 Financial Results 80
  • 6.5 Nov 09, 2016: Corentec to Raise USD17.6 Million in Private Placement of Bonds Due 2021 81
  • 6.6 Nov 09, 2016: Materialise Reports Third Quarter 2016 Results 81
  • 6.7 Nov 03, 2016: Smith & Nephew Third Quarter 2016 Trading Report 83
  • 6.8 Nov 02, 2016: Wright Medical Group Reports 2016 Third Quarter Financial Results and Updates 2016 Guidance 85
  • 6.9 Nov 01, 2016: Intellijoint Surgical Raises USD8.2 Million in Series A Financing 86
  • 6.10 Oct 31, 2016: Zimmer Biomet Reports Third Quarter 2016 Financial Results 87
  • 6.11 Oct 31, 2016: Exactech Q3 Revenue Up 7% to $59.9 Million. Net Income up 10% to $3.2 Million. Diluted EPS $0.22 vs. $0.20. 87
  • 6.12 Oct 31, 2016: Orthofix International Reports Third Quarter 2016 Financial Results 89
  • 6.13 Oct 27, 2016: Stryker reports third quarter 2016 results 90
  • 6.14 Oct 21, 2016: Corin Orthopaedics Acquires Hip/Knee Business from Wright Medical for USD32.3 Million 91
  • 6.15 Oct 06, 2016: Amedica Provides Business Update 91
  • 6.16 Oct 05, 2016: Henry Ford Health System Announces New CEO of Health Alliance Plan 92
  • 6.17 Oct 05, 2016: Amedica Announces Workforce Reduction 92
  • 6.18 Sep 23, 2016: Implanet Announces Its 2016 First-Half Results: Buoyant Growth in Revenue and Substantial Gross Margin Improvement 93
  • 6.19 Sep 23, 2016: RMS Medical Products Posts Second Quarter 2017 Results 94
  • 6.20 Sep 20, 2016: Mount Carmel Health System announces Edward Lamb as new President and CEO 95
  • 6.21 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 96
  • 6.22 Sep 13, 2016: Orthogrid Systems Raises USD0.4 Million in Financing 97
  • 6.23 Aug 31, 2016: Tecomet May Sell Itself 97
  • 6.24 Aug 31, 2016: HealthTrust Awards University of Miami Health Care an Innovation Grant to Build 'Life Skills Gym' for Total Joint Replacement Patients 97
  • 6.25 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 98
  • 6.26 Aug 25, 2016: Thammasat University Aims More Awards at the International Exhibition of Inventions of Geneva 100
  • 6.27 Aug 19, 2016: Amedica Announces Receipt of Nasdaq Notice of Bid Price Deficiency 101
  • 6.28 Aug 11, 2016: Amedica Reports Second Quarter 2016 Financial Results 101
  • 6.29 Aug 11, 2016: Materialise Reports Second Quarter 2016 Results 102
  • 6.30 Aug 02, 2016: Wright Medical Group Reports 2016 Second Quarter Financial Results and Increases 2016 Guidance 104
  • 6.31 Aug 01, 2016: JRI Orthopaedics Acquires Sheffield Medical Products 106
  • 6.32 Aug 01, 2016: Exactech Q2 Revenue Up 8% to $66.1 Million; Net Income up 20% to $4.4 Million; Diluted EPS $0.31 vs. $0.26 107
  • 6.33 Aug 01, 2016: Orthofix International Reports Second Quarter 2016 Financial Results 108
  • 6.34 Jul 28, 2016: Smith & Nephew Second Quarter Trading and First Half 2016 Results 109
  • 6.35 Jul 28, 2016: Zimmer Biomet Reports Second Quarter 2016 Financial Results 112
  • 6.36 Jul 21, 2016: Stryker reports second quarter 2016 results 113
  • 6.37 Jul 18, 2016: Direct Anterior Approach for Hip Replacement now available at Frisbie 114
  • 6.38 Jul 12, 2016: Implanet: Q2 2016 Record Revenue of €2.1 Million with Spine Sales Growing by +68% 114
  • 6.39 Jul 11, 2016: CFO to leave Smith & Nephew in early 2017 115
  • 6.40 Jul 07, 2016: Study Launched to Evaluate Early Outcomes of Different Hip Replacement Techniques Using Portable Gait Analysis System 115
  • 6.41 Jul 05, 2016: United Orthopedic (UOC) Donates Orthopedic Replacement Systems to Hospital in China 116
  • 6.42 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 117
  • 6.43 Jun 29, 2016: New chairman appointed at JRI Orthopaedics 117
  • 6.44 Jun 17, 2016: New Study Reveals Hip Arthroscopy Effective Treatment For Hip Impingement: Outcome Varies Depending On Patient's Age And Sex 118
  • 6.45 Jun 14, 2016: EU ruling on medical devices 119
  • 6.46 Jun 13, 2016: Zimmer Biomet Raises USD1.28 Billion in Public Offering of Shares 119
  • 6.47 Jun 07, 2016: Corin's Optimized Positioning System (OPS) receives 510(k) clearance 119
  • 6.48 Jun 07, 2016: Zimmer Biomet Plans to Raise USD750 Million in Public Offering of Notes 120
  • 6.49 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 120
  • 6.50 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 121
  • 6.51 May 23, 2016: Wright Medical to Raise Funds in Public Offering of Shares 123
  • 6.52 May 20, 2016: Amedica Raises USD12.7 Million in Public Offering of Units 123
  • 6.53 May 19, 2016: New Data and Milestones Back Medacta's Orthopedic Surgery Product Line Following 8th M.O.R.E. International Symposium 124
  • 6.54 May 19, 2016: Beijing Chunlizhengda Medical Instruments Announces Resignation And Appointment Of Chief Financial Officer 125
  • 6.55 May 13, 2016: Wright Medical to Raise USD395 Million in Private Placement of 2.25% Notes Due 2021 126
  • 6.56 May 12, 2016: Amedica Reports First Quarter 2016 Financial Results 126
  • 6.57 May 05, 2016: Smith & Nephew 2016 First Quarter Trading Report 127
  • 6.58 May 04, 2016: Wright Medical Group Reports 2016 First Quarter Financial Results and Increases 2016 Guidance 128
  • 6.59 Apr 28, 2016: Implanet: Q1 2016 revenues Strong increase in U.S. JAZZ sales: +106% 130
  • 6.60 Apr 28, 2016: Zimmer Biomet Holdings Reports First Quarter 2016 Financial Results 131
  • 6.61 Apr 28, 2016: Orthofix International Reports First Quarter 2016 Financial Results 131
  • 6.62 Apr 26, 2016: Exactech Q1 Revenue Up 6% to $65.3 Million. Net Income of $4.4 Million. Diluted EPS $0.31 vs. $0.29 132
  • 6.63 Apr 20, 2016: Stryker reports first quarter 2016 results 133
  • 6.64 Apr 18, 2016: Henry Ford Breast Cancer Program Granted 3-Year Accreditation 134
  • 6.65 Apr 13, 2016: Implanet Commences Trading on OTCQX in the U.S. 134
  • 6.66 Apr 12, 2016: Heard Robins Cloud Congratulates Plaintiffs for $500 Million Verdict in DePuy Hip Implant Trial 135
  • 6.67 Apr 05, 2016: Allegiance Health Joins Henry Ford Health System 135
  • 6.68 Mar 30, 2016: Implanet Announces 2015 Annual Results 136
  • 6.69 Mar 23, 2016: Amedica First to 3D Print Silicon Nitride for Medical Applications 138
  • 6.70 Mar 17, 2016: Simmons Hanly Conroy Announces Plaintiffs' $502 Million Bellwether Trial Verdict Against Johnson & Johnson over Faulty DePuy Pinnacle Hip Replacement Device 138
  • 6.71 Mar 17, 2016: Amedica Reports Fourth Quarter and Full Year 2015 Financial Results 139
  • 6.72 Mar 16, 2016: India Life Sciences Fund Invests in Biorad Medisys 140
  • 6.73 Mar 16, 2016: Intellijoint Surgical Enters into Distribution Agreement with Corin 140
  • 6.74 Mar 10, 2016: Humana Launches Value-Based Orthopedic Specialty Care Model in Ohio 140
  • 6.75 Mar 10, 2016: Exactech Announces Completion of Corporate Integrity Agreement Requirements 141
  • 6.76 Mar 04, 2016: Smith & Nephew : Annual Financial Report 141
  • 6.77 Mar 03, 2016: Stryker Raises USD750 Million in Public Offering of 2% Notes Due 2019 145
  • 6.78 Mar 03, 2016: Stryker Raises USD1 Billion in Public Offering of 4.625% Notes Due 2046 145
  • 6.79 Mar 03, 2016: Stryker Raises USD1 Billion in Public Offering of 3.5% Notes Due 2026 145
  • 6.80 Mar 03, 2016: Stryker Raises USD750 Million in Public Offering of 2.625% Notes Due 2021 146
  • 6.81 Mar 02, 2016: Zimmer Biomet Announces Commercial Launch of the Echo Bi-Metric Microplasty Stem 146
  • 6.82 Mar 02, 2016: Zimmer Biomet Announces Commercial Launch of the G7 Dual Mobility Construct 147
  • 6.83 Mar 02, 2016: Zimmer Biomet Announces Commercial Launch of the Arcos One-Piece Revision System 147
  • 6.84 Mar 01, 2016: Smith & Nephew unveils our first 3D-printed titanium hip implant 147
  • 6.85 Mar 01, 2016: Medacta Showcases Latest Surgical Innovation Mpact Acetabular System at American Academy of Orthopaedic Surgeons Annual Meeting 148
  • 6.86 Mar 01, 2016: CoorsTek Medical Announces FDA 510(k) Clearance for Total Hip System Incorporating CeraSurf-p Implantable Ceramic Components 149
  • 6.87 Mar 01, 2016: Exactech Innovations Simplify the Complexity of Revision Total Joint Replacement 149
  • 6.88 Feb 29, 2016: Orthofix International Reports Fourth Quarter and Fiscal 2015 Financial Results 150
  • 6.89 Feb 18, 2016: Amedica to Present 24-Month CASCADE Clinical Trial Results 152
  • 6.90 Feb 16, 2016: Exactech 2015 Revenue $241.8 Million, Net Income $14.8 Million, EPS $1.04 152
  • 6.91 Feb 09, 2016: Amedica Regains Compliance With Nasdaq Listing Requirements and Announces Capitalization Improvements 153
  • 6.92 Feb 04, 2016: Smith & Nephew Fourth Quarter Trading and Full Year 2015 Results 154
  • 6.93 Jan 28, 2016: Zimmer Biomet Holdings Reports Fourth Quarter and Full-Year 2015 Financial Results 157
  • 6.94 Jan 28, 2016: Amedica to Present Research Supporting Favorable Silicon Nitride Findings at the Orthopaedic Research Society Annual Meeting 158
  • 6.95 Jan 26, 2016: Stryker Reports 2015 Results and 2016 Outlook 158
  • 6.96 Jan 26, 2016: Stryker Announces the Retirement of William R. Jellison and the promotion of Glenn S. Boehnlein to Vice President, Chief Financial Officer 159
  • 6.97 Jan 26, 2016: IMPLANET announces results for the 4th quarter and full year to 31 December 2015 160
  • 6.98 Jan 19, 2016: OrthAlign Announces Upcoming Commercial Launch of OrthAlign Plus for Direct Anterior Total Hip Replacement 160
  • 6.99 Jan 12, 2016: Stryker Provides 2015 Preliminary Sales Results and Increases Adjusted Earnings Guidance 161
  • 6.100 Jan 12, 2016: Orthofix Announces Preliminary Fourth Quarter 2015 and Full Year Net Sales Results 162
  • 6.101 Jan 07, 2016: Intellijoint Surgical Receives FDA Clearance for the Next Generation of intellijoint HIP -- A Miniature Surgical Smart Tool for Cup Position, Leg Length, and Offset in Hip Replacement Surgery 163
  • 6.102 Dec 30, 2015: Amedica Signs International Private Label Supply Agreement With Chinese Orthopedic Company 163
  • 6.103 Dec 23, 2015: EQT to Acquire Limacorporate from Ardian 164
  • 6.104 Dec 16, 2015: HYPREVENTION Raised € 750,000 to Finance the Y-STRUT Product Launch, a Unique Medical Device to Prevent Hip Fracture 164
  • 6.105 Dec 16, 2015: Hyprevention Raises USD0.8 Million in Financing Round 164
  • 6.106 Dec 07, 2015: ulrich medical USA Settles Lawsuit against Amedica 165

7 Appendix 166

  • 7.1 Methodology 166
  • 7.2 About GlobalData 169
  • 7.3 Contact Us 169
  • 7.4 Disclaimer 169

List of Tables

  • Table 1: Hip Reconstruction - Pipeline Products by Stage of Development 13
  • Table 2: Hip Reconstruction - Pipeline Products by Segment 14
  • Table 3: Hip Reconstruction - Pipeline Products by Territory 15
  • Table 4: Hip Reconstruction - Pipeline Products by Regulatory Path 16
  • Table 5: Hip Reconstruction - Pipeline Products by Estimated Approval Date 17
  • Table 6: Hip Reconstruction - Ongoing Clinical Trials 18
  • Table 7: Hip Reconstruction Companies - Pipeline Products by Stage of Development 19
  • Table 8: Hip Reconstruction - Pipeline Products by Stage of Development 21
  • Table 9: 4-Web Spine, LLC Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 10: Truss Implant - Hip Procedures - Product Status 23
  • Table 11: Truss Implant - Hip Procedures - Product Description 23
  • Table 12: Amedica Corporation Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 13: Infinia Total Hip Implant II - Product Status 24
  • Table 14: Infinia Total Hip Implant II - Product Description 25
  • Table 15: Bonovo Orthopedics Inc Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 16: JMM Total Hip System - Product Status 26
  • Table 17: JMM Total Hip System - Product Description 26
  • Table 18: Konknow Hip System - Product Status 27
  • Table 19: Konknow Hip System - Product Description 27
  • Table 20: Corentec Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 21: Bencox ID Cemented Stem - Collarless - Product Status 28
  • Table 22: Bencox ID Cemented Stem - Collarless - Product Description 29
  • Table 23: DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 24: Bone Preserving Hip Stem - Product Status 30
  • Table 25: Bone Preserving Hip Stem - Product Description 31
  • Table 26: DeltaMotion Hip System - Product Status 31
  • Table 27: DeltaMotion Hip System - Product Description 31
  • Table 28: Hip Resurfacing System - Product Status 32
  • Table 29: Hip Resurfacing System - Product Description 32
  • Table 30: New Poly Hip Bearing - Product Status 32
  • Table 31: New Poly Hip Bearing - Product Description 33
  • Table 32: Next Generation Hip System - Product Status 33
  • Table 33: Next Generation Hip System - Product Description 33
  • Table 34: DePuy Synthes Inc - Ongoing Clinical Trials Overview 34
  • Table 35: DeltaMotion Hip System - A Multi-center, Prospective, Uncontrolled Post Market Clinical Follow-up Study (PMCFS) to Monitor the Survival and Performance of the DeltaMotion Cup System in Subjects Requiring a Total Hip Replacement 35
  • Table 36: DeltaMotion Hip System - RSA-Measured in Vivo Migration and Micromotion in the DePuy Tri-lock, Corail and Deltamotion Hip Replacement Components: A Single-blinded Randomised Control Trial 35
  • Table 37: Exactech Inc Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 38: Alteon Acetabular System - Product Status 36
  • Table 39: Alteon Acetabular System - Product Description 37
  • Table 40: Alteon HA System - Product Status 37
  • Table 41: Alteon HA System - Product Description 37
  • Table 42: Alteon Revision Modular System - Product Status 38
  • Table 43: Alteon Revision Modular System - Product Description 38
  • Table 44: Exactech GPS Hip System - Product Status 38
  • Table 45: Exactech GPS Hip System - Product Description 39
  • Table 46: Hip Revision System - Product Status 39
  • Table 47: Hip Revision System - Product Description 39
  • Table 48: HIP Wedge Stem - Product Status 40
  • Table 49: HIP Wedge Stem - Product Description 40
  • Table 50: Fortis Orthopedics Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 51: MiHip System - Product Status 41
  • Table 52: MiHip System - Product Description 41
  • Table 53: Fraunhofer Institute for Applied Polymer Research Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 54: Enhanced Durability Resurfacing Endoprosthesis - Product Status 42
  • Table 55: Enhanced Durability Resurfacing Endoprosthesis - Product Description 43
  • Table 56: Implants International Limited Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 57: Phoenix Re-Surf - Product Status 44
  • Table 58: Phoenix Re-Surf - Product Description 44
  • Table 59: INOR Orthopaedics Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 60: INOR TOTAL HIP SYSTEM Chromium Cobalt XL Series-LONG NECK - Product Status 45
  • Table 61: INOR TOTAL HIP SYSTEM Chromium Cobalt XL Series-LONG NECK - Product Description 45
  • Table 62: INOR TOTAL HIP SYSTEM Stainless Steel XL Series-Long Neck - Product Status 46
  • Table 63: INOR TOTAL HIP SYSTEM Stainless Steel XL Series-Long Neck - Product Description 46
  • Table 64: JRI Orthopaedics Ltd Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 65: Customised Hip Replacement Component - Product Status 47
  • Table 66: Customised Hip Replacement Component - Product Description 47
  • Table 67: KYOCERA Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 68: Aquala Liner - Product Status 48
  • Table 69: Aquala Liner - Product Description 48
  • Table 70: Limacorporate S.p.a. Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 71: DELTA-ONE-TT - Product Status 49
  • Table 72: DELTA-ONE-TT - Product Description 50
  • Table 73: DELTA-Revision TT - Product Status 50
  • Table 74: DELTA-Revision TT - Product Description 51
  • Table 75: MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 52
  • Table 76: Anterior Approach THA Instrument - Product Status 52
  • Table 77: Anterior Approach THA Instrument - Product Description 53
  • Table 78: Next Generation Optimized ML Taper Hip Stem - Product Status 53
  • Table 79: Next Generation Optimized ML Taper Hip Stem - Product Description 53
  • Table 80: Total Hip Prosthesis - Product Status 54
  • Table 81: Total Hip Prosthesis - Product Description 54
  • Table 82: Universal Inline Broach Handle - Product Status 54
  • Table 83: Universal Inline Broach Handle - Product Description 55
  • Table 84: XL & E-POLY BIOFOAM - Product Status 55
  • Table 85: XL & E-POLY BIOFOAM - Product Description 55
  • Table 86: MX Orthopedics, Corp. Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 87: Shape Memory Alloy Hip Implant - Product Status 56
  • Table 88: Shape Memory Alloy Hip Implant - Product Description 56
  • Table 89: Nano Interface Technology LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 90: Hip Implant - Product Status 57
  • Table 91: Hip Implant - Product Description 57
  • Table 92: OrthoGrid Systems Pipeline Products & Ongoing Clinical Trials Overview 58
  • Table 93: HipFXGrid - Product Status 58
  • Table 94: HipFXGrid - Product Description 58
  • Table 95: PLD Corporation Limited (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 59
  • Table 96: M-COR Primary Press-Fit - Product Status 59
  • Table 97: M-COR Primary Press-Fit - Product Description 59
  • Table 98: PreSRV Ltd. Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 99: Atlas Femoral Head Preserving Prosthesis - Product Status 60
  • Table 100: Atlas Femoral Head Preserving Prosthesis - Product Description 60
  • Table 101: Renova Orthopedics, LLC Pipeline Products & Ongoing Clinical Trials Overview 61
  • Table 102: A-FX Hip Fracture System - Product Status 61
  • Table 103: A-FX Hip Fracture System - Product Description 61
  • Table 104: Rochester Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 62
  • Table 105: Artificial Hip Joint - Product Status 62
  • Table 106: Artificial Hip Joint - Product Description 62
  • Table 107: SINTEF Pipeline Products & Ongoing Clinical Trials Overview 63
  • Table 108: Smart Hip Prosthesis - Product Status 63
  • Table 109: Smart Hip Prosthesis - Product Description 63
  • Table 110: Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview 64
  • Table 111: Navio Total Hip Arthroplasty System - Product Status 64
  • Table 112: Navio Total Hip Arthroplasty System - Product Description 65
  • Table 113: REDAPT Revision System - Product Status 65
  • Table 114: REDAPT Revision System - Product Description 65
  • Table 115: Stryker Corporation Pipeline Products & Ongoing Clinical Trials Overview 66
  • Table 116: Hip Distraction Device - Product Status 66
  • Table 117: Hip Distraction Device - Product Description 67
  • Table 118: MITCH TRH System - Product Status 67
  • Table 119: MITCH TRH System - Product Description 67
  • Table 120: University of Alberta Pipeline Products & Ongoing Clinical Trials Overview 68
  • Table 121: Hip Replacement And Bone Loss Monitor - Product Status 68
  • Table 122: Hip Replacement And Bone Loss Monitor - Product Description 68
  • Table 123: University of Auckland Pipeline Products & Ongoing Clinical Trials Overview 69
  • Table 124: Acetabular Reconstruction Implant - Product Status 69
  • Table 125: Acetabular Reconstruction Implant - Product Description 69
  • Table 126: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 70
  • Table 127: Cannulated Screw Jig - Product Status 70
  • Table 128: Cannulated Screw Jig - Product Description 70
  • Table 129: Injectable Hip Hemiarthroplasty Device - Product Status 71
  • Table 130: Injectable Hip Hemiarthroplasty Device - Product Description 71
  • Table 131: University of Warwick Pipeline Products & Ongoing Clinical Trials Overview 72
  • Table 132: Femoral Head Positioning Device - Product Status 72
  • Table 133: Femoral Head Positioning Device - Product Description 72
  • Table 134: Hip Prostheses - Product Status 73
  • Table 135: Hip Prostheses - Product Description 73
  • Table 136: Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 74
  • Table 137: Durom Full Resurfacing Hip - Product Status 74
  • Table 138: Durom Full Resurfacing Hip - Product Description 75
  • Table 139: E1 Avantage Hip Cup - Product Status 75
  • Table 140: E1 Avantage Hip Cup - Product Description 75
  • Table 141: ReCap Total Hip Resurfacing System - Product Status 76
  • Table 142: ReCap Total Hip Resurfacing System - Product Description 76
  • Table 143: Zimmer Biomet Holdings Inc - Ongoing Clinical Trials Overview 77
  • Table 144: E1 Avantage Hip Cup - Evaluation of Cemented and Cementless Fixation of Dual-mobility Hip Prosthesis in Elderly Patients With Osteoarthritis 78
  • Table 145: E1 Avantage Hip Cup - RCT of the Sirius Stem Used in Conjunction with the Exceed ABT Cemented Cup and OptiPac/OptiVac Cement - Model Based RSA, Clinical and Radiographic Outcomes 78
  • Table 146: Glossary 167

List of Figures

  • Figure 1: Hip Reconstruction - Pipeline Products by Stage of Development 13
  • Figure 2: Hip Reconstruction - Pipeline Products by Segment 14
  • Figure 3: Hip Reconstruction - Pipeline Products by Territory 15
  • Figure 4: Hip Reconstruction - Pipeline Products by Regulatory Path 16
  • Figure 5: Hip Reconstruction - Pipeline Products by Estimated Approval Date 17
  • Figure 6: Hip Reconstruction - Ongoing Clinical Trials 18
Back to Top